文献速递免疫规划卫生政策与健康促进

ADVANCE系统测试:能否利用欧洲电子医疗数据库估计百日咳疫苗接种覆盖率:一个实例

ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.
PubMed 文献 · Vaccine · 2019-10-31

ADVANCE项目评估欧洲电子医疗数据库估计百日咳疫苗覆盖率可行性,纳入四国七个数据库2,575,576名儿童。结果显示剂量3覆盖率丹麦88-97%、英国96-100%、西班牙95-98%、意大利94%,多数与国家估计接近,仅意大利低3%。

要点

  • 利用电子医疗数据库可对百日咳免疫覆盖率给出一致性估计。
  • 剂量3覆盖率丹麦88-97%、英国96-100%、西班牙95-98%、意大利94%。
  • 多数国家估计与国家估计相差1-6%,意大利低3%。

核心结论

  • 本研究显示利用所纳入的电子医疗数据库可提供一致的百日咳免疫覆盖率估计,且估计值与国家估计可比。

研究设计与样本

  • 研究纳入丹麦2个、英国2个、西班牙2个和意大利1个共7个电子医疗数据库,儿童从出生随访至6岁。
  • 疫苗接种暴露从数据库获取,按类型(无细胞百日咳aP或全细胞百日咳wP)和剂次1、2、3分类。
  • 覆盖率采用期间患病率估计;对2006年出生队列,各数据库比较期间患病率和累积发病率两种估计方法。

主要发现

  • 纳入的2,575,576名儿童多数在国家推荐年龄接种疫苗。
  • 剂量3覆盖率丹麦88-97%(2003-2014年出生队列)、英国96-100%(2003-2014年)、西班牙95-98%(2004-2014年)、意大利94%(2006-2007年)。
  • 丹麦和英国各出生队列剂量3覆盖率与国家估计相差1-6%,本研究估计多偏高。
  • 西班牙剂量3覆盖率与国家估计相差0-2%,无一致高估或低估;意大利估计比国家估计低3%。
  • 除意大利两种方法结果相同外,累积发病率覆盖率估计一致比期间患病率估计低1-10%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for rapid benefit-risk (B/R) monitoring of vaccines, using existing healthcare databases in Europe. The objective of this paper was to assess the feasibility of using electronic healthcare databases to estimate dose-specific acellular pertussis (aP) and whole cell pertussis (wP) vaccine coverage. METHODS: Seven electronic healthcare databases in four European countries (Denmark (n = 2), UK (n = 2), Spain (n = 2) and Italy (n = 1)) participated in this study. Children were included from birth and followed up to age six years. Vaccination exposure was obtained from the databases and classified by type (aP or wP), and dose 1, 2 or 3. Coverage was estimated using period prevalence. For the 2006 birth cohort, two estimation methods for pertussis vaccine coverage, period prevalence and cumulative incidence were compared for each database. RESULTS: The majority of the 2,575,576 children included had been vaccinated at the country-specific recommended ages. Overall, the estimated dose 3 coverage was 88-97% in Denmark (birth cohorts from 2003 to 2014), 96-100% in the UK (2003-2014), 95-98% in Spain (2004-2014) and 94% in Italy (2006-2007). The estimated dose 3 coverage per birth cohort in Denmark and the UK differed by 1-6% compared with national estimates, with our estimates mostly higher. The estimated dose 3 coverage in Spain differed by 0-2% with no consistent over- or underestimation. In Italy, the estimates were 3% lower compared with the national estimates. Except for Italy, for which the two coverage estimation methods generated the same results, the estimated cumulative incidence coverages were consistently 1-10% lower than period prevalence estimates. CONCLUSION: This study showed that it was possible to provide consistent estimates of pertussis immunisation coverage from the electronic healthcare databases included, and that the estimates were comparable with the national estimates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Emborg HD, Kahlert J, Braeye T, et al. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example. Vaccine. 2019. PMID: 31677953. doi:10.1016/j.vaccine.2019.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。